Literature DB >> 16987879

RNA-dominant diseases.

Robert J Osborne1, Charles A Thornton.   

Abstract

Several examples have come to light in which mutations in non-protein-coding regions give rise to a deleterious gain-of-function by non-coding RNA. Expression of the toxic RNA is associated with formation of nuclear inclusions and late-onset degenerative changes in brain, heart or skeletal muscle. In the best studied example, myotonic dystrophy, it appears that the main pathogenic effect of the toxic RNA is to sequester binding proteins and compromise the regulation of alternative splicing. This review describes some of the recent advances in understanding the pathophysiology of RNA-dominant diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987879     DOI: 10.1093/hmg/ddl181

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  100 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.

Authors:  Rosanna Cardani; Marzia Giagnacovo; Annalisa Botta; Fabrizio Rinaldi; Alessandra Morgante; Bjarne Udd; Olayinka Raheem; Sini Penttilä; Tiina Suominen; Laura V Renna; Valeria Sansone; Enrico Bugiardini; Giuseppe Novelli; Giovanni Meola
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

Review 3.  RNA-mediated neurodegeneration in repeat expansion disorders.

Authors:  Peter K Todd; Henry L Paulson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

4.  Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.

Authors:  Devika P Gates; Leslie A Coonrod; J Andrew Berglund
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

5.  Nanopore analysis of individual RNA/antibiotic complexes.

Authors:  Meni Wanunu; Swati Bhattacharya; Yun Xie; Yitzhak Tor; Aleksei Aksimentiev; Marija Drndic
Journal:  ACS Nano       Date:  2011-11-16       Impact factor: 15.881

6.  Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.

Authors:  Olayinka Raheem; Shodimu-Emmanuel Olufemi; Linda L Bachinski; Anna Vihola; Mario Sirito; Jeanette Holmlund-Hampf; Hannu Haapasalo; Yi-Ping Li; Bjarne Udd; Ralf Krahe
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

7.  Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1.

Authors:  Marianna Teplova; Dinshaw J Patel
Journal:  Nat Struct Mol Biol       Date:  2008-11-30       Impact factor: 15.369

Review 8.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

Review 9.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

10.  Small molecules that target the toxic RNA in myotonic dystrophy type 2.

Authors:  Lien Nguyen; JuYeon Lee; Chun-Ho Wong; Steven C Zimmerman
Journal:  ChemMedChem       Date:  2014-06-17       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.